(Q30994738)

28 June 2017

1 reference

title

Photodynamic therapy in the treatment of subfoveal choroidal neovascularisation (English)

1 reference

28 June 2017

1 reference

S Harding

1

1 reference

28 June 2017

1 June 2001

1 reference

28 June 2017

1 reference

28 June 2017

15

1 reference

28 June 2017

Pt 3

1 reference

28 June 2017

407-412

1 reference

Mechanisms of tumor necrosis induced by photodynamic therapy

28 June 2017

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2001.145

Closure of experimental subretinal neovascular vessels with dihematoporphyrin ether augmented argon green laser photocoagulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2001.145

Low density lipoprotein transport across a microvascular endothelial barrier after permeability is increased

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2001.145

Liposomal benzoporphyrin derivative verteporfin photodynamic therapy. Selective treatment of choroidal neovascularization in monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2001.145

Intravenous infusion of liposomal benzoporphyrin derivative for photodynamic therapy of experimental choroidal neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2001.145

In vivo uptake of liposomal benzoporphyrin derivative and photothrombosis in experimental corneal neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2001.145

Photodynamic therapy of experimental choroidal melanoma using lipoprotein-delivered benzoporphyrin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2001.145

Photodynamic therapy of pigmented choroidal melanomas using a liposomal preparation of benzoporphyrin derivative

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2001.145

Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of a single treatment in a phase 1 and 2 study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2001.145

Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of retreatments in a phase 1 and 2 study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2001.145

The impact of the macular photocoagulation study results on the treatment of exudative age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2001.145

Photodynamic Therapy of Subfoveal Choroidal Neovascularization in Age-related Macular Degeneration With Verteporfin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2001.145

Prevalence of age-related maculopathy. The Beaver Dam Eye Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2001.145

7 January 2021

The prevalence of age-related maculopathy in the Rotterdam Study

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2001.145

7 January 2021

Age-related macular degeneration

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2001.145

7 January 2021

Laser photocoagulation of subfoveal neovascular lesions in age-related macular degeneration. Results of a randomized clinical trial. Macular Photocoagulation Study Group

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2001.145

7 January 2021

Visual outcome after laser photocoagulation for subfoveal choroidal neovascularization secondary to age-related macular degeneration. The influence of initial lesion size and initial visual acuity. Macular Photocoagulation Study Group

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2001.145

7 January 2021

Treatment of senile disciform macular degeneration: a single-blind randomised trial by argon laser photocoagulation. The Moorfields Macular Study Group

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2001.145

7 January 2021

Vascular Endothelium as the Vulnerable Element in Tumours

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2001.145

7 January 2021

Vascular targeting in photodynamic occlusion of subretinal vessels

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2001.145

7 January 2021

Is it time for a national screening programme for sight-threatening diabetic retinopathy?

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2001.145

7 January 2021

Dimensions Publication ID

Identifiers

DOI

10.1038/EYE.2001.145

0 references

1051070261

0 references

Fatcat ID

release_7kfr2mxnofcphae5hrh4y3ee2u

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/7kfr2mxnofcphae5hrh4y3ee2u

24 November 2022

mapped directly with Wikidata item

PubMed ID

11450766

1 reference

PubMed ID

11450766